HOME >> BIOLOGY >> NEWS
'Why isn't the neural tube defects rate lower?,' asks March of Dimes

DALLAS - June 19, 2001 - Researchers at UT Southwestern Medical Center at Dallas report that administering replacement estrogen via a skin patch is superior to oral estrogen replacement therapy in lowering blood pressure and sympathetic nerve activity - the neural control of blood pressure - in postmenopausal women.

The study, published in today's issue of Circulation, is the first to compare the effectiveness of oral and transdermal replacement therapies on sympathetic nerve activity in humans.

These findings suggest that how estrogen is administered is the key in optimizing the beneficial effects of estrogen replacement therapy on blood pressure, said Dr. Wanpen Vongpatanasin, assistant professor of internal medicine in hypertension and lead author of the study.

"Prevalence of hypertension is very low in young pre-menopausal women but increases markedly after menopause, suggesting a protective role of estrogen on blood pressure. Knowledge from this study may lead to an effective therapy to treat or prevent hypertension after menopause," she said.

Vongpatanasin and her colleagues reported that transdermal estrogen, or the estrogen patch, decreased nerve activity in postmenopausal women with normal blood pressure by 30 percent. The researchers also reported a small, but statistically significant, decrease in blood pressure in patients taking transdermal estrogen.

Both nerve activity and blood pressure were unaffected in patients taking oral estrogen. "This is an initial step that leads us to think that all estrogen preparations are not the same," Vongpantanasin said.

"This may be one of the reasons why large clinical trials failed to show a benefit of estrogen replacement therapy on blood pressure or any cardiovascular outcomes. It could very well be because only oral estrogen, the most popular preparation in the United States, has been used rather than transdermal estrogen."

Postmenopausal w
'"/>

Contact: Michele Kling
mkling@modimes.org
914-997-4613
March of Dimes Birth Defects Foundation
19-Jun-2001


Page: 1 2 3

Related biology news :

1. Two warbler species find the West isnt big enough for both of them
2. Bigger isnt always better--especially if youre a rodent
3. Meow isnt language, but enough to manage humans
4. Caffeine in colas: The Real Thing isnt the taste
5. Knock knock knocking on rhythms neural doors
6. Molecule awakens and maintains neural connections
7. DHEA boosts growth rate of human neural stem cells
8. UC Berkeley scientists detail neural circuit that lets eye detect directional motion
9. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
10. The brain uses the same neural networks to engage in conscious and unconscious learning
11. Astrocytes play starring role in neural stem cell development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2020)... ... August 21, 2020 , ... The August edition ... and is now available on the company’s global website. Crystallography Times—an electronic newsletter ... presenting current news and crystallographic research. , The latest issue of Crystallography ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary to ... Roche and J&J have annual Research and Development spending in excess of US ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... company announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to provide ... clients to strengthen their laboratory supply chain for more than 10 years. Early ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 29, 2020 , ... The Interlocal ... contracts to its membership, recently named BioFit Engineered Products an Awarded ... to purchase ergonomic seating, cafeteria tables, book trucks and carts at discounted pricing ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading provider ... for businesses of all types to ensure cleanliness, distancing and occupancy with its patent ... Safe Space™ enabled business will provide a health performance index system that scores all ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping ... at University of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine ...
Breaking Biology Technology:
Cached News: